Auckland University’s Dr Ehsan Vaghefi, CEO and co-founder of Toku Eyes, has just launched the company’s second AI retinal screening product, Oraicle, in the US. The company’s technology saves sight and lives by identifying those most at risk of diabetic retinopathy and cardiovascular events. So why is Australasia now lagging behind the US, asked Drew Jones.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
